Breaking News From Pharma & Bio Ingredients
Matrixx Reports Big Jump in Revenue
Posted on 2005-10-25 17:03:00
Matrixx Initiatives, Inc., an over-the-counter healthcare company said third quarter revenue increased 49% to approximately $25.2 million and income jumped more than 60% to $5.6 million. The improvement in sales and earnings during the third quarter is primarily due to initial shipments of the new Zicam Flu products and Nasal Comfort line as well as higher sales of existing Zicam products.
For the nine months ended Sept. 30, 2005, revenues increased 40% to approximately $46.4 million and net income grew 84% for the nine months ended Sept. 30, 2005 to approximately $6 million.
Subscribe via RSS
